Overview

Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers

Status:
Completed
Trial end date:
2017-07-03
Target enrollment:
Participant gender:
Summary
This study will be to compare the pharmacokinetics of nalmefene administration intranasal with and without an absorption enhancer compared to an intramuscular injection.
Phase:
Phase 1
Details
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Treatments:
Nalmefene
Naltrexone